HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Scott R Walker Selected Research

Histones (Histone)

10/2023Discovery of a highly potent, selective, orally bioavailable inhibitor of KAT6A/B histone acetyltransferases with efficacy against KAT6A-high ER+ breast cancer.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Scott R Walker Research Topics

Disease

1Breast Neoplasms (Breast Cancer)
10/2023
1Neoplasms (Cancer)
10/2023
1Lymphopenia (Lymphocytopenia)
10/2010

Drug/Important Bio-Agent (IBA)

1Estrogens (Estrogen)FDA Link
10/2023
1RNA Polymerase II (RNA Polymerase B)IBA
10/2023
1Histones (Histone)IBA
10/2023
1Histone Acetyltransferases (Histone Acetyltransferase)IBA
10/2023
1Lysine AcetyltransferasesIBA
10/2023
1Immunosuppressive Agents (Immunosuppressants)IBA
10/2010
1Fingolimod Hydrochloride (FTY720)FDA Link
10/2010
1Sphingosine-1-Phosphate ReceptorsIBA
10/2010
1sphingosine kinaseIBA
10/2010
1LipidsIBA
10/2010
1SphingosineIBA
10/2010

Therapy/Procedure

1Therapeutics
10/2023